Agios Pharmaceuticals | AGIO - Trade Creditors


Agios Pharmaceuticals reported $18.36M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Agios Pharmaceuticals USD 18.36M 1.2M Dec/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
Astellas Pharma JPY 181.95B 13.3B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Bayer EUR 7.08B 700M Dec/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Daiichi Sankyo JPY 568.5B 16.84B Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Exelixis USD 29.62M 4.27M Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Incyte USD 1.63B 1.46B Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Merck USD 4.15B 102M Sep/2025
Moderna USD 317M 50M Dec/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025